May 162018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye, today announced that Steven Boyd has joined its board.… => Read full post

EyeGate Pharmaceuticals appoints Steven Boyd to its Board of Directors

From:: EyeGate Pharmaceuticals appoints Steven Boyd to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: